Increased sensitivity in detection of a porcine high-turnover osteopenia after total gastrectomy by dynamic F-fluoride ion PET and quantitative CT

Journal of Nuclear Medicine

Volumn 44, Issue 1, 2003, Pages 117-124

  Piert, Morand ^a   Zittel, Tilman T ^b   Jahn, Michael ^b   Stahlschmidt, Anke ^b   Becker, Georg A ^b   Machulla, Hans Jürgen ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

18F fluoride ion PET; Bone metabolic activity; Bone mineral density; Postgastrectomy bone disease; Quantitative CT; Total gastrectomy

Indexed keywords

CALCITRIOL; FLUORINE 18; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; BONE BLOOD FLOW; BONE DENSITY; BONE MASS; BONE MATRIX; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCIUM HOMEOSTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; EVALUATION; FEMALE; ISOTOPE LABELING; NONHUMAN; OSTEOLYSIS; OSTEOMALACIA; OSTEOPENIA; OUTCOMES RESEARCH; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SWINE; TECHNIQUE; TOTAL STOMACH RESECTION; VERTEBRA BODY; VITAMIN BLOOD LEVEL;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; FLUORINE RADIOISOTOPES; GASTRECTOMY; LUMBAR VERTEBRAE; MODELS, BIOLOGICAL; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWINE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037225173     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tovey FI, Hall ML, EII PJ, Hobsley M. A review of postgastrectomy bone disease. J Gastroenterol Hepatol. 1992;7:639-645.
2. Maier GW, Kreis ME, Zittel TT, Becker HD. Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg. 1997;225:181-192.
3. Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S. Osteoporosis after gastrectomy: bone mineral density of lumbar spine assessed by dual-energy x-ray absorptiometry. Calcif Tissue Int. 2000;66:119-122.
4. Nihei Z, Kojima K, Ichikawa W, Hirayama R, Mishima Y. Chronological changes in bone mineral content following gastrectomy. Surg Today, 1996;26: 95-100.
5. Liedman B, Henningsson A, Mellstrom D, Lundell L. Changes in bone metabolism and body composition after total gastrectomy: results of a longitudinal study. Dig Dis Sci. 2000;45:819-824.
6. Zittel TT, Zeeb B, Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997;174:431-438.
7. Heiskanen JT, Kröger H, Pääkkönen M, Parviainen MT, Lamberg-Allardt C, Alhava E. Bone mineral metabolism after total gastrectomy. Bone. 2001;1:123-127.
8. Rumenapf G, Schwille PO, Erben RG, et al. Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis. Calcif Tissue Int. 1998;63:433-441.
9. Wojtyczka A, Gorka Z, Bierzynska-Macyszyn G, Rumenapf G, Jonderko K, Schwille PO. Gastrectomy in the rat using two modifications of esophagojejunal anastomoses: general status, local histological changes and relationships to bone density. Eur Surg Res. 1999;31:497-507.
10. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of skeletal kinetics of fluoride-18-fluoride ion with PET. J Nucl Med. 1992;33:633-642.
11. 18F]fluoride ion PET: correlation with bone histomorphometry. J Nucl Med. 2001;42:1091-1100.
12. 18F]fluoride ion and dynamic positron emission tomography. Eur J Nucl Med. 1995;22:1133-1140.
13. Piert M, Winter E, Becker GA, et al. Allogenic bone graft viability after revision hip arthroplasty. Eur J Nucl Med. 1999;26:615-624.
14. 18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab. 1993;77: 949-955.
15. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-1976.
16. 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res. 2000;15:763-769.
17. 18F]flouride ion PET in porcine vertebrae. J Bone Miner Res. 1998;13:1328-1336.
18. Payne RB, Carver ME, Morgan DB. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol. 1979;32:32-56.
19. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscle. Am J Physiol. 1959;197:1205-1210.
20. Crone C. The permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand. 1964;58;292-305.
21. Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut. 1991;32:1303-1307.
22. Inoue K, Shiomi K, Higashide S, et al. Metabolic bone disease following gastrectomy: assessment by dual energy x-ray absorptiometry. Br J Surg. 1992; 79:321-324.
23. Mellström D, Johansson C, Johnell O, et al. Osteoporosis, metabolic alterations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int. 1993;53:370-377.
24. 47Ca in patients with partial gastrectomy. Digestion. 1975;12:193-200.
25. Davies M, Heys SE, Selby PL, Berry JL, Mawer EB. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels: implications for metabolic bone disease. J Clin Endocrinol Metab. 1997;82:209-212.
26. Rumenapf G, Schwille PO, Erben RG, et al. Osteopenia following total gastrectomy in the rat: state of mineral metabolism and bone histomorphometry. Eur Surg Res. 1997;29:209-221.
27. 2-vitamin D concentrations in healthy men. Kidney Int. 1983;24:555-560.
28. Potts JT Jr, Jüppner H. Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism, and bone development: the proteins, their genes, and receptors. In: Avioli LV, Krane SM, eds. Metabolic Bone Disease and Clinically Related Disorders. San Diego, CA: Academic Press; 1998:52-94.
29. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA. 1999;96:3540-3545.
30. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new member of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20:345-357.
31. Heath DA. Regulation of calcium metabolism: hypercalcaemia. In: Grossman A, ed. Clinical Endocrinology. 2nd ed. London, U.K.: Blackwell; 1998:551-562.
32. Kalender WA, Brestowsky H, Felsenberg D. Automated determination of the midvertebral slice for CT bone mineral measurement. Radiology. 1988; 168:219-221.
33. Kalender WA, Felsenberg D, Louis O, et al. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol. 1989;9:75-80.
34. Einhom TA, Vigorita VJ, Aaron A. Localization of technetium-99m methylene diphosphonate in bone using microautoradiography. J Orthop Res. 1986;4:180-187.
35. Mühlbauer RC, Schenk RK, Chen D, Lehto-Axtelius D, Hakanson R. Morphometric analysis of gastrectomy-evoked osteopenia. Calcif Tissue Int. 1998;62: 323-326.
36. Whitford GM. Intake and metabolism of fluoride. Adv Dent Res. 1994;8:5-14.
37. 18F]fluoride ion positron emission tomography. Eur J Nucl Med. 2002;29:907-914.